New diabetes clinical trial: Effect of Agave Inulin Supplementation on Metabolic Profile and Intestinal Abundance of Bifidobacterium and Lactobacillaceae in Adults With Type 2 Diabetes Mellitus

Published on: 2026-07-10T04:00:00Z
Conditions: Type 2 Diabetes; Gut Microbiota; Insulin Resistance; Metabolic Syndrome; Prebiotic
Interventions: Dietary Supplement: Agave Inulin; Dietary Supplement: Maltodextrin (Placebo)
Sponsors: Universidad Autonoma de Queretaro; Instituto Nacional de Medicina Genomica
Active, not recruiting
https://ift.tt/lU8LRH5